Project Number 1RF1AG064859-01 Agency/Funding Organization NIA Funding Year 2019 View Full Project Details for Pre-clinical efficacy of a selective p38MAPK inhibitor in a model of comorbid Alzheimer/vascular pathology Research Categorization Primary Disease / Condition Vascular Dementia/Dysfunction Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 4. Non-clinical Drug Development (small molecules and biologics) r. Multi-target Researcher and Organization Principal Investigator VAN ELDIK, LINDA J Principal Investigator First Name LINDA Principal Investigator Last Name VAN ELDIK Awardee Organization UNIVERSITY OF KENTUCKY Awardee State Kentucky Contact PI Country United States Project Detail Funding Opportunity Announcement PA-18-484: NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed) FY Overall Cost $2,872,820 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official REFOLO, LORENZO
